June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Executives Buy Around $5M Of 3 Penny Stocks

Published 21/04/2022, 13:28
© Reuters.  Executives Buy Around $5M Of 3 Penny Stocks
IXIC
-
CLAR
-
BDI
-
BDTX
-
INZY
-

US stocks closed mixed on Wednesday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Black Diamond Therapeutics

  • The Trade: Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) 10% owner BB Biotech Ag acquired a total of 300,000 shares at an average price of $3.27. To acquire these shares, it cost $980.58 thousand.
  • What’s Happening: Black Diamond Therapeutics recently said first patient was dosed in Phase 1 study of BDTX-1535, a masterkey inhibitor of EGFR for the treatment of glioblastoma and non-small cell lung cancer.
  • What Black Diamond Therapeutics Does: Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies.
Inozyme Pharma
  • The Trade: Inozyme Pharma, Inc. (NASDAQ: INZY) Director Pivotal bioVenture Partners Fund I U.G.P., Ltd acquired a total of 1,070,000 shares at an average price of $3.69. The insider spent around $3.95 million to buy those shares.
  • What’s Happening: The company recently announced an underwritten offering of 16,276,987 shares of its common stock at $3.69 per share for gross proceeds of $73 million.
  • What Inozyme Pharma Does: Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton.
Also check this: Insiders Buy More Than $15M Of 3 Stocks

Don’t forget to check out our premarket coverage here .

Societal CDMO

  • The Trade: Societal CDMO, Inc. (NASDAQ: SCTL) 10% owner AWM Investment Company Inc acquired a total of 27,700 shares at an average price of $1.55. To acquire these shares, it cost around $43.03 thousand.
  • What’s Happening: The company recently announced the addition of new employees to fill open roles throughout the organization.
  • What Societal CDMO Does: Societal CDMO, Inc is a contract development and manufacturing organization.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.